This page has been robot translated, sorry for typos if any. Original content here.

Attention! Information is for reference only!
Before taking, be sure to consult a doctor!
SITE ONLY DIRECTORY. NOT A PHARMACY! We do not sell medicines! None!

Medication Description: Dexrazoxane (Dexrazoxane)

DEXRASOXANE (Dexrazoxane).

(+) - (S) -1,4-Propylene-2,6-piperazinedione.

Synonym: Cardioxan, Cardioxan.

White crystalline powder. Well soluble in water.

Cyclic analogue of EDTA (ethylenediaminetetraacetic acid).

Forms chelate bonds with salts of iron and copper.

Violates the formation of the doxorubicin-iron complex (and other anthracycline antibiotics with iron), and also prevents the appearance of iron-containing free radicals that mediate the cardiotoxicity of anthracycline antitumor antibiotics.

Prescribed for the prevention of cardiomyopathy with the use of anthracycline anti-tumor antibiotics.

Adults are administered intravenously at a dose of 0.5 g / m 2 (0.5 g is dissolved in 0.167 M sodium lactate solution to a concentration of 10 mg / ml or in 0.9% sodium chloride solution or 5% glucose solution to a concentration of 1.3 -5 mg / ml) 30 minutes before intravenous administration of doxorubicin at a dose of 50 mg / m 2 or (Scheme II) at a dose of 1 g / m 2 (0.5 g is dissolved in 25 ml of water for injection, then in Ringer’s lactate solution or sodium lactate to 250-500 ml) for 45-60 minutes before the administration of doxorubicin (first 20-30 minutes infusion, then 20-30 minutes break). Bred ex tempore. The solution is valid for 6 hours after preparation.

Possible side effects: dyspepsia, alopecia, leukopenia, thrombocytopenia, pain at the injection site.

The drug is contraindicated in pregnancy and lactation.

Product form: lyophilized powder for injection solutions in vials of 0.5 g, complete with solvent.

Storage: List B.